➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson

Last Updated: August 4, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,440,029

Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,440,029
Title:Drive mechanism for a drug delivery device and drug delivery device
Abstract: The drive mechanism comprises a lead screw (5) and a lead screw nut, which are aligned with an axis (4). The lead screw has screw threads (6, 16) having the same pitch and being intertwined.
Inventor(s): Plumptre; David Aubrey (Droitwich Spa, GB)
Application Number:13/825,812
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;

Drugs Protected by US Patent 9,440,029

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,440,029

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
10186732Oct 6, 2010
PCT Information
PCT FiledOctober 05, 2011PCT Application Number:PCT/EP2011/067416
PCT Publication Date:April 12, 2012PCT Publication Number: WO2012/045792

International Family Members for US Patent 9,440,029

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 083298 ⤷  Free Forever Trial
Australia 2011311615 ⤷  Free Forever Trial
Brazil 112013006964 ⤷  Free Forever Trial
Canada 2812717 ⤷  Free Forever Trial
China 103179998 ⤷  Free Forever Trial
European Patent Office 2438949 ⤷  Free Forever Trial
European Patent Office 2624892 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.